WEIGAO GROUP1066.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 16, 2026, WEIGAO GROUP (1066.HK) trades at a P/E of 9.65x, P/B of 0.54x, P/S of 0.98x, and a dividend yield of 5.04%.
Longitudinal percentile comparison: P/E sits at the 10th percentile over the trailing 10Y window (vs. 33rd percentile over 3Y); P/B sits at the 2nd percentile over the trailing 10Y window (vs. 6th percentile over 3Y); P/S sits at the 2nd percentile over the trailing 10Y window (vs. 6th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 29th percentile within its industry and the 44th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 6.31%, ranking at the 98th percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 8.3 points, pointing to a consistent valuation read across both metrics. Relative to industry peers, its P/E shows a deeper discount than it does against the broader market. Breaking down the total shareholder yield: 5.04% comes from cash dividends, with an implied ~1.27% from buybacks — a fairly balanced mix of both channels. WEIGAO GROUP operates in the Other Pharmaceuticals and Medical Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 1066 · SEHK: 1066 · 1066
Want the full picture on whether WEIGAO GROUP (1066.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 9.65 | ||||||
| P/B (MRQ) | 0.54 | ||||||
| P/S (TTM) | 0.98 | ||||||
| Dividend Yield | 5.04% | ||||||
| Buyback + Div Yield | 6.31% |